Cause of death, by non-communicable diseases, ages 60+, male in South Asia (IDA & IBRD)
South Asia (IDA & IBRD): Cause of death, by non-communicable diseases, ages 60+, male was 51.0% in 2021. ▬ Flat
Cause of death, by non-communicable diseases, ages 60+, male in South Asia (IDA & IBRD), 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total male deaths ages 60+.
Analysis
The most recent figure for cause of death, by non-communicable diseases, ages 60+, male in South Asia (IDA & IBRD) is 51.0%, measured in 2021. That is the lowest value across all 6 years on record.
The figure is down 29.3% on the previous year and down 30.7% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 60+, male in South Asia (IDA & IBRD) peaked at 80.8% in 2019 and was at its lowest, 51.0%, in 2021.
That places South Asia (IDA & IBRD) 46th out of 47 groups with data for 2021, putting it in the bottom quarter.
Cause of death, by non-communicable diseases, ages 60+, male in South Asia (IDA & IBRD), year by year
| Year | % of total male deaths ages 60+ | Change |
|---|---|---|
| 2000 | 65.9% | — |
| 2010 | 73.6% | +11.7% |
| 2015 | 77.7% | +5.6% |
| 2019 | 80.8% | +3.9% |
| 2020 | 72.2% | -10.6% |
| 2021 | 51.0% | -29.3% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 65.9% | 65.9% | 65.9% | 1 |
| 2010s | 77.4% | 73.6% | 80.8% | 3 |
| 2020s | 61.6% | 51.0% | 72.2% | 2 |
Countries ranked near South Asia (IDA & IBRD)
More health data for South Asia (IDA & IBRD)
- Population ages 45-49, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 10-14, female, per capita 0.0406 units per person (2025)
- Population ages 50-54, female, annual growth rate 2.35 % change on previous year (2025)
- Population ages 45-49, male, per capita 0.0305 units per person (2025)
- Population ages 45-49, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 10-14, male, annual growth rate -1.31 % change on previous year (2025)
- Population ages 45-49, male, annual growth rate 2.55 % change on previous year (2025)
- Population ages 45-49, female, per capita 0.029 units per person (2025)
- Population ages 40-44, male, annual growth rate 2.39 % change on previous year (2025)
- Population ages 10-14, male, per capita 0.0444 units per person (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 60+, male in South Asia (IDA & IBRD)?
- Cause of death, by non-communicable diseases, ages 60+, male in South Asia (IDA & IBRD) was 51.0% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 60+, male recorded in South Asia (IDA & IBRD)?
- The highest recorded value was 80.8% in 2019.
- What is the lowest cause of death, by non-communicable diseases, ages 60+, male recorded in South Asia (IDA & IBRD)?
- The lowest recorded value was 51.0% in 2021.
- How does South Asia (IDA & IBRD) rank for cause of death, by non-communicable diseases, ages 60+, male?
- South Asia (IDA & IBRD) ranks 46th out of 47 groups with data for 2021.
- Is cause of death, by non-communicable diseases, ages 60+, male rising or falling in South Asia (IDA & IBRD)?
- Over the last ten years it is down 30.7%. The long-run trend across the full record is flat.
- Where does this South Asia (IDA & IBRD) data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 60+, male (% of total male deaths ages 60+). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of male deaths ages 60+ due to non-communicable diseases divided by number of all male deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.